Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Cameron

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Scientific Reports|December 22, 2015
Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilmsShoufeng Yang, Iain D Hay, David R Cameron, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2023
Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort studyMelissa Pitton, Luca G Valente, Simone Oberhaensli, et al.
Plos Pathogens|December 14, 2020
Bacterial persisters in long-term infection: Emergence and fitness in a complex host environmentJennifer A Bartell, David R Cameron, Biljana Mojsoska, et al.
Plos One|January 13, 2012
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureusAnton Y Peleg, Spiros Miyakis, Doyle V Ward, et al.
FEMS Microbes|June 19, 2023
Isolation and characterization of bacteriophages from the human skin microbiome that infect <i>Staphylococcus epidermidis</i>Luca G Valente, Melissa Pitton, Monika Fürholz, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX geneKristoffer T Bæk, Louise Thøgersen, René G Mogenssen, et al.
BMC Research Notes|September 28, 2021
Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSALuca G Valente, Lea Federer, Manuela Iten, et al.
Plos One|April 26, 2022
Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat modelLuca G Valente, Ngoc Dung Le, Melissa Pitton, et al.
The Journal of Infectious Diseases|December 21, 2012
The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureusWei Gao, David R Cameron, John K Davies, et al.
Artificial Organs|December 8, 2022
Ten-year retrospective cohort analysis of ventricular assist device infectionsGiancarlo Spano, Eric Buffle, Laura Naëmi Walti, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Scientific Reports|December 22, 2015
Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilmsShoufeng Yang, Iain D Hay, David R Cameron, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 28, 2023
Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort studyMelissa Pitton, Luca G Valente, Simone Oberhaensli, et al.
Plos Pathogens|December 14, 2020
Bacterial persisters in long-term infection: Emergence and fitness in a complex host environmentJennifer A Bartell, David R Cameron, Biljana Mojsoska, et al.
Plos One|January 13, 2012
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureusAnton Y Peleg, Spiros Miyakis, Doyle V Ward, et al.
FEMS Microbes|June 19, 2023
Isolation and characterization of bacteriophages from the human skin microbiome that infect <i>Staphylococcus epidermidis</i>Luca G Valente, Melissa Pitton, Monika Fürholz, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX geneKristoffer T Bæk, Louise Thøgersen, René G Mogenssen, et al.
BMC Research Notes|September 28, 2021
Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSALuca G Valente, Lea Federer, Manuela Iten, et al.
Plos One|April 26, 2022
Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat modelLuca G Valente, Ngoc Dung Le, Melissa Pitton, et al.
The Journal of Infectious Diseases|December 21, 2012
The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureusWei Gao, David R Cameron, John K Davies, et al.
Artificial Organs|December 8, 2022
Ten-year retrospective cohort analysis of ventricular assist device infectionsGiancarlo Spano, Eric Buffle, Laura Naëmi Walti, et al.
Pageof 4